← Return to NSCLC KRAS G12V Stage 2A treatment?

Discussion

NSCLC KRAS G12V Stage 2A treatment?

Lung Cancer | Last Active: Jun 23 11:30am | Replies (8)
Comment receiving replies
@dalegantous

What about Folfirinox? In Canada (where I am) it is the standard of care post resection. I was stage 2B. I had Whipple Feb.9, am having 12 rounds of Folfirinox, number 6 tomorrow. Also I was in an immunotherapy clinical trial prior to surgery, durvalumab and oleclumab.

Jump to this post

Replies to "What about Folfirinox? In Canada (where I am) it is the standard of care post resection...."
Lisa, Volunteer Mentor | @lls8000 | Jun 23 11:06am

Hi @dalegantous, From what I'm finding Folfirinox has been successful for pancreatic cancers, but I'm not seeing that it's been used for EGFR or other lung cancers. Sometimes drugs for one cancer are applicable to other cancers, if the drivers of the cancer are similar. Do you have experience with this drug in non-pancreatic cancers?

VIEW AND REPLY